Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 15994709)


Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States.

Post RM, Altshuler LL, Leverich GS, Nolen WA, Kupka R, Grunze H, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Rowe M.

Prim Care Companion CNS Disord. 2014 Dec 18;16(6). doi: 10.4088/PCC.14m01677. eCollection 2014.


Sex differences in mania phenotype and ethanol consumption in the lateral hypothalamic kindled rat model.

Abulseoud OA, Gawad NA, Mohamed K, Vadnie C, Camsari UM, Karpyak V, Frye MA, Choi DS.

Transl Psychiatry. 2015 Mar 24;5:e534. doi: 10.1038/tp.2015.30.


Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies.

Young AH, Calabrese JR, Gustafsson U, Berk M, McElroy SL, Thase ME, Suppes T, Earley W.

Int J Bipolar Disord. 2013 Jul 4;1:10. doi: 10.1186/2194-7511-1-10. eCollection 2013.


Saving time and money: a validation of the self ratings on the prospective NIMH Life-Chart Method (NIMH-LCM).

Born C, Amann BL, Grunze H, Post RM, Schärer L.

BMC Psychiatry. 2014 May 7;14:130. doi: 10.1186/1471-244X-14-130.


P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1.

Backlund L, Lavebratt C, Frisén L, Nikamo P, Hukic Sudic D, Träskman-Bendz L, Landén M, Edman G, Vawter MP, Ösby U, Schalling M.

PLoS One. 2012;7(8):e43057. doi: 10.1371/journal.pone.0043057. Epub 2012 Aug 28.


CRY2 is associated with rapid cycling in bipolar disorder patients.

Sjöholm LK, Backlund L, Cheteh EH, Ek IR, Frisén L, Schalling M, Osby U, Lavebratt C, Nikamo P.

PLoS One. 2010 Sep 9;5(9):e12632. doi: 10.1371/journal.pone.0012632.


Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders.

Gao K, Chan PK, Verduin ML, Kemp DE, Tolliver BK, Ganocy SJ, Bilali S, Brady KT, Findling RL, Calabrese JR.

Am J Addict. 2010 Sep-Oct;19(5):440-9. doi: 10.1111/j.1521-0391.2010.00060.x.


Bipolar disorder with frequent mood episodes in the New Zealand Mental Health Survey.

Wells JE, McGee MA, Scott KM, Oakley Browne MA.

J Affect Disord. 2010 Oct;126(1-2):65-74. doi: 10.1016/j.jad.2010.02.136. Epub 2010 Mar 21.


Rapid-cycling bipolar disorder: cross-national community study.

Lee S, Tsang A, Kessler RC, Jin R, Sampson N, Andrade L, Karam EG, Mora ME, Merikangas K, Nakane Y, Popovici DG, Posada-Villa J, Sagar R, Wells JE, Zarkov Z, Petukhova M.

Br J Psychiatry. 2010 Mar;196(3):217-25. doi: 10.1192/bjp.bp.109.067843.


Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessment.

Gao K, Tolliver BK, Kemp DE, Ganocy SJ, Bilali S, Brady KL, Findling RL, Calabrese JR.

J Clin Psychiatry. 2009 Jul;70(7):1032-40.


Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R).

Nierenberg AA, Akiskal HS, Angst J, Hirschfeld RM, Merikangas KR, Petukhova M, Kessler RC.

Mol Psychiatry. 2010 Nov;15(11):1075-87. doi: 10.1038/mp.2009.61. Epub 2009 Jun 30.


A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders.

Meade CS, McDonald LJ, Graff FS, Fitzmaurice GM, Griffin ML, Weiss RD.

Bipolar Disord. 2009 Jun;11(4):425-33. doi: 10.1111/j.1399-5618.2009.00682.x. Epub 2009 Apr 15.


A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.

Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR.

J Clin Psychiatry. 2009 Jan;70(1):113-21. Epub 2008 Dec 30.


Rapid cycling bipolar disorders in primary and tertiary care treated patients.

Hajek T, Hahn M, Slaney C, Garnham J, Green J, Růzicková M, Zvolský P, Alda M.

Bipolar Disord. 2008 Jun;10(4):495-502. doi: 10.1111/j.1399-5618.2008.00587.x.


The prevalence and correlates of workplace depression in the national comorbidity survey replication.

Kessler RC, Merikangas KR, Wang PS.

J Occup Environ Med. 2008 Apr;50(4):381-90. doi: 10.1097/JOM.0b013e31816ba9b8.


Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder.

Gao K, Tolliver BK, Kemp DE, Verduin ML, Ganocy SJ, Bilali S, Brady KT, Shim SS, Findling RL, Calabrese JR.

J Affect Disord. 2008 Sep;110(1-2):167-73. doi: 10.1016/j.jad.2007.12.229. Epub 2008 Jan 29.


The prevalence and significance of substance use disorders in bipolar type I and II disorder.

Cerullo MA, Strakowski SM.

Subst Abuse Treat Prev Policy. 2007 Oct 1;2:29.


Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC.

Arch Gen Psychiatry. 2007 May;64(5):543-52. Erratum in: Arch Gen Psychiatry. 2007 Sep;64(9):1039.


Pharmacological treatment of bipolar disorder among children and adolescents.

Blader JC, Kafantaris V.

Expert Rev Neurother. 2007 Mar;7(3):259-70. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk